Yumei Wu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- Cancer, Lipids, and Metabolism 3
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 22
-
- Ovarian cancer diagnosis and treatment 10
- Endometriosis Research and Treatment 5
-
- Cervical Cancer and HPV Research 13
-
- Advanced battery technologies research 4
-
- Ferroptosis and cancer prognosis 3
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yumei Wu
53 papers receiving 585 citations
Peers
Comparison fields: 5 of 109
- Cancer Research 190
- Obstetrics and Gynecology 90
- Reproductive Medicine 40
- Epidemiology 118
- Molecular Biology 215
Countries citing papers authored by Yumei Wu
This map shows the geographic impact of Yumei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumei Wu more than expected).
Fields of papers citing papers by Yumei Wu
This network shows the impact of papers produced by Yumei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumei Wu. The network helps show where Yumei Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yumei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 23 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 0 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 6 | |
| 15 | Study of clinical diagnosis of cervical glandular intraepithelial neoplasia. | 2016 | 1 |
| 16 | 2016 | 35 | |
| 17 | [Clinical analysis of patients underwent hysterectomy for stage I cervical cancer or high grade cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia]. | 2015 | 5 |
| 18 | 2015 | 27 | |
| 19 | Study on Betaine by Electrospray Ionization Mass Spectrometry | 2011 | 1 |
| 20 | 2010 | 75 |
About Yumei Wu
Yumei Wu is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 62 papers that have together received 598 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (22 papers), Cervical Cancer and HPV Research (13 papers), Ovarian cancer diagnosis and treatment (10 papers), Cancer-related molecular mechanisms research (5 papers), Endometriosis Research and Treatment (5 papers), Advanced battery technologies research (4 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (190 citations), Obstetrics and Gynecology (90 citations) and Reproductive Medicine (40 citations). Yumei Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Aihui Liu, Xiunan Li, Xin Tang, Zhiwei Wang, Yue He, Chang‐Ying Hu, Yamei Wang, Limin Feng, Yuxiang Zhang and Xue Xiao. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.